Motley Rice has reached an Agreement in Principle to settle with transvaginal mesh (TVM) device manufacturer American Medical Systems, Inc. (AMS) and parent company Endo International plc.
On Monday, April 28, 2014, in one of the few cases interpreting the Alien Tort Statute (ATS) post the Supreme Court’s ruling in Kiobel v. Royal Dutch Shell Petroleum, U.S. District Judge Jose Linares denied motions to dismiss filed by Defendants concerning the extraterritorial reach of the ATS in Krishanti, et al., v. Rajaratnam, et al.
Motley Rice is proud to announce that several of its attorneys, who represent clients across an array of practice areas, have been selected for inclusion in the 2014 South Carolina Super Lawyers and Rising Stars lists and 2014 Washington, D.C. Super Lawyers list.
The 2014 editions of Benchmark Plaintiff and Benchmark Litigation were released and include multiple mentions of Motley Rice attorneys.
Four of Motley Rice’s members are included in the 2014 edition of Benchmark Plaintiff’s inaugural Top 150 Women in Litigation list.
Motley Rice was a proud sponsor of the 10th annual International Asbestos Awareness Conference, presented by the Asbestos Disease Awareness Organization (ADAO).
On Monday, April 7, a federal court jury in Louisiana decided that Takeda Pharmaceuticals and Eli Lilly hid the risks of bladder cancer from the diabetes drug, Actos.
Motley Rice is reviewing potential claims involving the proposed acquisition of SWS Group, Inc. (“SWS” or the “Company”) (NYSE: SWS) by Hilltop Holdings Inc. (“Hilltop”) (NYSE: HTH).